Sprout Pharmaceuticals, Inc.
PrivateLast Round
VC Round
Sep 4, 2019
Est. Valuation
$1B
Total Funding Raised
$130M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sprout Pharmaceuticals, Inc. is a pharmaceutical company that develops and markets treatments for women's sexual health, most notably the FDA-approved medication Addyi for the treatment of Hypoactive Sexual Desire Disorder (HSDD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sprout Pharmaceuticals, Inc. Comparables
Compare Sprout Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cosette Pharmaceuticals, Inc. | 80% | |
| S1 Biopharma, Inc. | 74% | |
| Freya Pharma Solutions | 71% |
Sprout Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 4, 2019 | ||||
| Debt | Nov 6, 2017 | ||||
| M&A | Aug 20, 2015 | ||||
| Series C | Jun 8, 2015 | ||||
| Series B | Jul 11, 2014 | ||||
Series A | Jun 25, 2013 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 48% MoM.
- Jan 29, 2026
Attended the 2026 Oprah Daily Menopause O-wards.
Sprout Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sprout Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Sprout Pharmaceuticals, Inc. a public or private company?
Sprout Pharmaceuticals, Inc. is a private company.
What is the current stock price of Sprout Pharmaceuticals, Inc.?
Sprout Pharmaceuticals, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Sprout Pharmaceuticals, Inc. worth (valuation)?
Sprout Pharmaceuticals, Inc.'s valuation is estimated at $1.0B based on funding round data.
Can I buy Sprout Pharmaceuticals, Inc. stock?
Sprout Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sprout Pharmaceuticals, Inc.'s last funding round?
Sprout Pharmaceuticals, Inc.'s most recent funding round was VC Round on August 20, 2015.
Who are the main investors in Sprout Pharmaceuticals, Inc.?
Investor information for Sprout Pharmaceuticals, Inc. is not publicly disclosed.
Will Sprout Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Sprout Pharmaceuticals, Inc..
How can I track Sprout Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sprout Pharmaceuticals, Inc.'s secondary market activity and sign up for updates.